A pilot study discovered that the FSHR Ser680Asn genotype does not influence the follicular fluid hormonal profile or ovulation outcomes in cycles stimulated with varying gonadotropin preparations. The research, involving 40 women undergoing ART, compared two genetic variants and determined no significant impact on treatment results.
Read More
Male Synchronized Swimmers Face Setback as Olympic Dreams Fade: Bill May's Story
Tragic Collision on Nakuru-Nairobi Highway Claims Lives of Woman and Four Children
Critical Negotiations Progress for Sh1.1 Trillion Adani Takeover of JKIA, CS Chirchir Comments
Vinicius Jr Surpasses Lionel Messi's Historic Record in UEFA Champions League
Manchester United's Pre-Season Triumph Against Real Betis: Rashford Injury Adds to Ten Hag's Selection Woes
